Akebia Therapeutics, Inc. (AKBA)
1.66
+0.03
(+1.84%)
USD |
NASDAQ |
Dec 11, 16:00
1.68
+0.02
(+1.20%)
After-Hours: 06:23
Akebia Therapeutics Research and Development Expense (Quarterly): 14.63M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Plus Therapeutics, Inc. | 2.436M |
| Ironwood Pharmaceuticals, Inc. | 21.99M |
| Pyxis Oncology, Inc. | 17.35M |
| Karyopharm Therapeutics, Inc. | 30.42M |